Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Allergy and Clinical Immunology. in Practice|September 10, 2021
Indoor Environmental Factors May Modify the Response to Mouse Allergen Reduction Among Mouse-Sensitized and Exposed Children with Persistent AsthmaS Christy Sadreameli, Ammara Ahmed, Jean Curtin-Brosnan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2019
Do Baseline Asthma and Allergic Sensitization Characteristics Predict Responsiveness to Mouse Allergen Reduction?Ammara Ahmed, S Christy Sadreameli, Jean Curtin-Brosnan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 22, 2020
Asthma Prevalence and Mold Levels in US Northeastern SchoolsEvin J Howard, Stephen J Vesper, Barbara J Guthrie, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 28, 2022
HEPA filtration intervention in classrooms may improve some students' asthmaStephen J Vesper, Larry Wymer, Brent A Coull, et al.
JAMA Network Open|October 10, 2025
Air Purifier Intervention for Respiratory Viral Exposure in Elementary Schools: A Secondary Analysis of a Randomized Clinical TrialYe Sun, Dastan Haghnazari, Ching-Ying Huang, et al.
Allergy and Asthma Proceedings|May 17, 2025
Cost-effectiveness of school integrated pest management and air filtration in students with asthmaCarmela Socolovsky, Margee Louisias, Saleh Alsulami, et al.
Contemporary Clinical Trials|June 17, 2017
The School Inner-City Asthma Intervention Study: Design, rationale, methods, and lessons learnedWanda Phipatanakul, Petros Koutrakis, Brent A Coull, et al.
JAMA|September 21, 2021
Effect of School Integrated Pest Management or Classroom Air Filter Purifiers on Asthma Symptoms in Students With Active Asthma: A Randomized Clinical TrialWanda Phipatanakul, Petros Koutrakis, Brent A Coull, et al.
Contemporary Clinical Trials|November 26, 2020
Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptationWanda Phipatanakul, David T Mauger, Theresa W Guilbert, et al.
Pageof 2